Mar 5, 2026 06:02AM

Mar 5, 2026 06:00AM

Mar 3, 2026 05:31PM

Mar 3, 2026 04:02PM

Feb 27, 2026 08:13AM

Feb 27, 2026 08:11AM

Feb 26, 2026 05:31PM Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight

Feb 26, 2026 06:30AM

Feb 26, 2026 06:30AM

Feb 23, 2026 09:03AM

Feb 23, 2026 09:00AM

Feb 23, 2026 09:00AM

Feb 23, 2026 05:56AM

Feb 23, 2026 05:05AM Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly

Feb 19, 2026 05:31PM

Feb 18, 2026 06:45AM

Feb 18, 2026 06:45AM

Feb 17, 2026 05:31PM

Feb 16, 2026 05:31PM

Feb 16, 2026 06:45AM

Feb 9, 2026 07:55AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY) Following Expert Call

Feb 9, 2026 06:53AM

Feb 6, 2026 04:51PM

Feb 5, 2026 10:24AM

Feb 4, 2026 06:45AM

Jan 20, 2026 07:45AM

Jan 20, 2026 07:45AM

Jan 16, 2026 11:23AM Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly

Jan 15, 2026 06:02AM

Jan 8, 2026 02:00PM

Jan 8, 2026 02:00PM

Dec 21, 2025 08:00PM

Dec 18, 2025 06:45AM

Dec 18, 2025 06:45AM

Dec 12, 2025 11:46AM Lilly reports updated breast cancer drug data at medical conference

Dec 12, 2025 11:45AM

Dec 12, 2025 06:10AM

Dec 12, 2025 06:01AM

Dec 9, 2025 07:37AM

Dec 9, 2025 07:30AM

Dec 7, 2025 04:30PM

Dec 7, 2025 04:30PM Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

Dec 3, 2025 01:00PM

Dec 3, 2025 12:59PM

Dec 1, 2025 04:04PM

Dec 1, 2025 08:18AM

Nov 24, 2025 04:30PM

Nov 24, 2025 04:30PM

Nov 24, 2025 12:00PM Lilly to present Jaypirca study data at ASH meeting in December

Nov 24, 2025 12:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All